CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Option exercise SVP of Research, CSO acquired 106,983 shares (option exercise)
- 4 Option exercise SVP of Research, CSO acquired 106,984 shares (option exercise)
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 1,668,746 shares at $3.18 ($5,309,950)
- SC 13G/A Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 10,000 shares at $3.18 ($31,800)
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Option exercise President, CEO acquired 166,759 shares (option exercise)
- 8-K Event Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
Page 20 of 34 · 678 filings